# An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma

> **NCT00599027** · PHASE3 · COMPLETED · sponsor: **Organon and Co** · enrollment: 51 (actual)

## Conditions studied

- Allergic Rhinitis
- Asthma

## Interventions

- **DRUG:** Mometasone furoate nasal spray (MFNS)
- **DRUG:** Placebo nasal spray

## Key facts

- **NCT ID:** NCT00599027
- **Lead sponsor:** Organon and Co
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-05
- **Primary completion:** 2009-05
- **Final completion:** 2009-05
- **Target enrollment:** 51 (ACTUAL)
- **Last updated:** 2024-05-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00599027

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00599027, "An Exploratory Study of Nasonex in Patients With Moderate to Severe Persistent Allergic Rhinitis and Intermittent Asthma". Retrieved via AI Analytics 2026-06-15 from https://api.ai-analytics.org/clinical/NCT00599027. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*